Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 7, Pages 3753
Publisher
MDPI AG
Online
2021-04-05
DOI
10.3390/ijms22073753
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer
- (2021) Irene Casanova-Salas et al. EUROPEAN UROLOGY
- Genetic predisposition to prostate cancer: an update
- (2021) Holly Ni Raghallaigh et al. Familial Cancer
- Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer
- (2021) Maria Teresa Vietri et al. MEDICAL ONCOLOGY
- Genetic Testing in Prostate Cancer
- (2020) Alexandra O. Sokolova et al. Current Oncology Reports
- ATM Serine/Threonine Kinase and its Role in Pancreatic Risk
- (2020) Neha Nanda et al. Genes
- Diagnosing hereditary cancer predisposition in men with prostate cancer
- (2020) Mary Pritzlaff et al. GENETICS IN MEDICINE
- Olaparib for Metastatic Castration-Resistant Prostate Cancer
- (2020) Johann de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer
- (2020) Tommi Rantapero et al. Genes
- Molecular Trajectory of BRCA1 and BRCA2 Mutations
- (2020) Yuichiro Hatano et al. Frontiers in Oncology
- Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications
- (2020) Andreia Brandão et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank
- (2020) Jun Wei et al. BRITISH JOURNAL OF CANCER
- Five Italian Families with Two Mutations in BRCA Genes
- (2020) Maria Teresa Vietri et al. Genes
- BRCA2 and Other DDR Genes in Prostate Cancer
- (2019) Paz Nombela et al. Cancers
- Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
- (2019) Piper Nicolosi et al. JAMA Oncology
- Targeting DNA Repair Defects for Precision Medicine in Prostate Cancer
- (2019) Alejandro Athie et al. Current Oncology Reports
- Exploiting DNA repair defects in colorectal cancer
- (2019) Nicole M. Reilly et al. Molecular Oncology
- Bringing prostate cancer germline genetics into clinical practice
- (2019) Sanjay Das et al. JOURNAL OF UROLOGY
- Treatment of Advanced Prostate Cancer
- (2019) Min Yuen Teo et al. Annual Review of Medicine
- A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges
- (2019) Indu Kohaar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Germline and Somatic Mutations in Prostate Cancer for the Clinician
- (2019) Heather H. Cheng et al. Journal of the National Comprehensive Cancer Network
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PARP Inhibitors in Prostate Cancer—The Preclinical Rationale and Current Clinical Development
- (2019) Virtanen et al. Genes
- First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis
- (2019) Zheng-Ju Ren et al. BMC CANCER
- Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
- (2019) Elizabeth C. Page et al. EUROPEAN UROLOGY
- Formal Methods for Prostate Cancer Gleason Score and Treatment Prediction using Radiomic Biomarkers
- (2019) Luca Brunese et al. MAGNETIC RESONANCE IMAGING
- Towards precision oncology in advanced prostate cancer
- (2019) Sheng-Yu Ku et al. Nature Reviews Urology
- Hereditary prostate cancer – Primetime for genetic testing?
- (2019) Isabel Heidegger et al. CANCER TREATMENT REVIEWS
- Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition
- (2018) Christos Mikropoulos et al. BRITISH JOURNAL OF CANCER
- Genetic testing for hereditary prostate cancer: Current status and limitations
- (2018) Jun Tu Zhen et al. CANCER
- Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide
- (2018) Emmanuel S. Antonarakis et al. EUROPEAN UROLOGY
- Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities
- (2018) Shyh-Han Tan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Screening for Prostate Cancer
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017
- (2018) Veda N. Giri et al. JOURNAL OF CLINICAL ONCOLOGY
- The Genomics of Prostate Cancer: A Historic Perspective
- (2018) Mark A. Rubin et al. Cold Spring Harbor Perspectives in Medicine
- Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer
- (2018) Paula Paulo et al. PLoS Genetics
- PD-1/PD-L1 pathway inhibitors in advanced prostate cancer
- (2018) Pedro Isaacsson Velho et al. Expert Review of Clinical Pharmacology
- Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
- (2018) David A. Quigley et al. CELL
- Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency
- (2018) Zafeiris Zafeiriou et al. EUROPEAN UROLOGY
- Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations
- (2018) Emmanuel S. Antonarakis et al. EUROPEAN UROLOGY
- Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
- (2018) Markus Mayrhofer et al. Genome Medicine
- Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
- (2017) Rong Na et al. EUROPEAN UROLOGY
- Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification
- (2017) Rick Kamps et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes
- (2017) Paula Paulo et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography
- (2017) Timothy R. Rebbeck SEMINARS IN RADIATION ONCOLOGY
- Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy
- (2017) Mark Thalgott et al. WORLD JOURNAL OF UROLOGY
- Prostate Cancer Germline Variations and Implications for Screening and Treatment
- (2017) Alexander Dias et al. Cold Spring Harbor Perspectives in Medicine
- PSA and Prostate Health Index based prostate cancer screening in a hereditary migration complicated population: implications in precision diagnosis
- (2017) Mariyam Akizhanova et al. Journal of Cancer
- Prevalence of theHOXB13G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness
- (2016) Tine M. Storebjerg et al. BJU INTERNATIONAL
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Familial prostate cancer
- (2016) Veda N. Giri et al. SEMINARS IN ONCOLOGY
- High burden of copy number alterations andc-MYCamplification in prostate cancer fromBRCA2germline mutation carriers
- (2015) E. Castro et al. ANNALS OF ONCOLOGY
- The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies
- (2015) J. L. Beebe-Dimmer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation
- (2015) Maria Teresa Vietri et al. Familial Cancer
- Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
- (2015) Lisa R. Susswein et al. GENETICS IN MEDICINE
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
- (2014) D Leongamornlert et al. BRITISH JOURNAL OF CANCER
- Prostate cancer incidence in males with Lynch syndrome
- (2014) Sigurdis Haraldsdottir et al. GENETICS IN MEDICINE
- A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment
- (2014) Heather Hampel et al. GENETICS IN MEDICINE
- The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial
- (2013) Z. Chen et al. CARCINOGENESIS
- A genome-wide association study of prostate cancer in West African men
- (2013) Michael Blaise Cook et al. HUMAN GENETICS
- Germline Mutations inHOXB13and Prostate-Cancer Risk
- (2012) Charles M. Ewing et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phosphorylation-regulated binding of Ctp1 to Nbs1 is critical for repair of DNA double-strand breaks
- (2011) Gerald E. Dodson et al. CELL CYCLE
- Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
- (2010) S M Edwards et al. BRITISH JOURNAL OF CANCER
- Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
- (2010) D. J. Gallagher et al. CLINICAL CANCER RESEARCH
- The DNA Damage Response: Making It Safe to Play with Knives
- (2010) Alberto Ciccia et al. MOLECULAR CELL
- DNA damage and decisions: CtIP coordinates DNA repair and cell cycle checkpoints
- (2010) Zhongsheng You et al. TRENDS IN CELL BIOLOGY
- A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
- (2009) Z Kote-Jarai et al. BRITISH JOURNAL OF CANCER
- Associations of High-Grade Prostate Cancer with BRCA1 and BRCA2 Founder Mutations
- (2009) I. Agalliu et al. CLINICAL CANCER RESEARCH
- PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization
- (2009) Shirley M.-H. Sy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- BRCA1 and its toolbox for the maintenance of genome integrity
- (2009) Michael S.Y. Huen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
- (2008) A Mitra et al. BRITISH JOURNAL OF CANCER
- The MRN complex
- (2008) Agnieszka Rupnik et al. CURRENT BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now